1. Responsibility. The board‘s responsibility for the control and regulation of the practice of pharmacy in this State includes, but is not limited to, the following actions:
A. The licensing by examination or by endorsement of applicants who are qualified to engage in the practice of pharmacy under this Act; [PL 2021, c. 289, §4 (AMD).]
B. The renewal of licenses to engage in the practice of pharmacy; [PL 1987, c. 710, §5 (NEW).]
C. The determination and issuance of standards for recognition and approval of degree programs of schools and colleges of pharmacy whose graduates shall be eligible for licensure in this State and the specification and enforcement of requirements for practical training, including internship; [PL 1987, c. 710, §5 (NEW).]
D. The inspection during business hours of all pharmacies, dispensaries, stores, hospital pharmacies, extended care facilities, boarding homes, nursing homes, substance use disorder treatment centers, penal institutions, family planning centers or other drug outlets in which drugs or medicines are manufactured, stored, distributed, compounded, dispensed or retailed in this State; [PL 2017, c. 407, Pt. A, §145 (AMD).]
E. The licensing of any pharmacy as set out in section 13751 and any manufacturer or wholesaler whose products are distributed in this State; [PL 2007, c. 402, Pt. DD, §7 (AMD).]
F. The enforcement of those provisions of this Act relating to the conduct or competence of pharmacists practicing in this State and the processing of complaints which could lead to the suspension, revocation or restriction of licenses to engage in the practice of pharmacy; [PL 1987, c. 710, §5 (NEW).]
G. The licensing of pharmacy interns and adoption of rules governing the training, qualification and employment of pharmacy interns and pharmacy students; and [PL 2011, c. 496, §2 (AMD).]
H. The licensing of pharmacy technicians, including the fee as set under section 13724, and adoption of rules governing the training, qualification and employment of pharmacy technicians. [PL 2007, c. 402, Pt. DD, §8 (AMD).]

[PL 2021, c. 289, §4 (AMD).]

Terms Used In Maine Revised Statutes Title 32 Sec. 13721

A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Manufacturer: means a person engaged in the manufacture of prescription drugs. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Pharmacy: means :
  • A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Pharmacy technician: means a person employed by a pharmacy who works in a supportive role to, and under the direct supervision of, a licensed pharmacist. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Practice of pharmacy: means the provision of health care services that include the interpretation and evaluation of prescription drug orders; the compounding, dispensing and labeling of drugs and devices, except labeling by a manufacturer, packer or distributor of nonprescription drugs and commercially packaged legend drugs and devices; the participation in drug selection and drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records for these drugs and devices; the administration of vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, or successor organization, for administration to adults; the administration to adults by intramuscular and subcutaneous injection of drugs approved by the United States Food and Drug Administration; the performance of collaborative drug therapy management; the responsibility for advising, when necessary or regulated, of therapeutic values, content, hazards and use of drugs and devices; the ordering and dispensing of over-the-counter nicotine replacement products approved by the United States Food and Drug Administration; the prescribing, dispensing and administering of an HIV prevention drug, as defined in section 13786?E, subsection 1, paragraph B, pursuant to a standing order or collaborative practice agreement or to protocols developed by the board; and the offering or performing of those acts, services, operations or transactions necessary in the conduct, operation, management and control of a pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Wholesaler: means a person who buys prescription drugs for resale and distribution to persons other than consumers. See Maine Revised Statutes Title 32 Sec. 13702-A
  • 2. Reciprocal inspections. The board may enter into reciprocal inspection agreements with any state in which a mail order prescription facility selling drugs to Maine citizens is located.

    [PL 1997, c. 245, §8 (AMD).]

    3. Pharmacist health program. The board may establish protocols for the operation of a professional review committee as defined in Title 24, section 2502, subsection 4?A. The protocols must include the committee’s reporting information the board considers appropriate regarding reports received, contracts or investigations made and the disposition of each report, as long as the committee is not required to disclose any personally identifiable information. The protocols may not prohibit an impaired pharmacist or pharmacy technician from seeking alternative forms of treatment.
    The board has the power to contract with other agencies, individuals, firms or associations for the conduct and operation of a pharmacist health program operated by a professional review committee as that term is defined in Title 24, section 2502, subsection 4?A.

    [PL 2007, c. 288, §2 (NEW).]

    SECTION HISTORY

    PL 1987, c. 710, §5 (NEW). PL 1997, c. 245, §§7,8 (AMD). PL 2005, c. 262, §B1 (AMD). PL 2007, c. 288, §2 (AMD). PL 2007, c. 402, Pt. DD, §§7, 8 (AMD). PL 2011, c. 496, §2 (AMD). PL 2017, c. 407, Pt. A, §145 (AMD). PL 2021, c. 289, §4 (AMD).